Physician profile
Michael Marchetti
NPI 1316384613
$504.06
in general payments reported to CMS, 2019-2025
14 companies · $250 in 2025
The $250 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.03 · 2021: $138 · 2022: $22.14 · 2023: $82.60 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polaris Technology Solutions LLC | $136.49 | 2025 | |
| Depuy Synthes Sales INC. | $82.60 | 2023 | Monovisc |
| Stryker Corporation | $64.98 | 2025 | Triathlon, Pangea |
| Abbvie INC. | $43.76 | 2021-2022 | |
| Bioventus LLC | $25.27 | 2025 | Xcell |
| Amarin Pharma, INC. | $24.88 | 2021 | |
| Cerapedics INC. | $23.43 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Sanofi-Aventis U.S. LLC | $19.33 | 2021 | |
| Lilly USA, LLC | $17.53 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $14.82 | 2021 | |
| Pfizer INC. | $14.70 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.15 | 2021 | |
| Genentech USA, INC. | $12.09 | 2021 | |
| Horizon Therapeutics Plc | $11.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Marchetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.